Shorted
Ecs Botanics Holdings logo
ECS
Pharmaceuticals, Biotechnology & Life Sciences

ECS Botanics Holdings

Short interest
0.13%
+0.12 pp 30d
as of 27 Feb 2024
Reported shorts
1.5M
Shares on issue
1.107B

ECS Botanics Holdings (ECS) company profile

Profile, insiders and operations

Company

AI-generated research profile of ECS Botanics Holdings

Pharmaceuticals
Biotechnology
Medicinal Cannabis
Organic Cultivation
ASX:ECS

ECS Botanics Holdings (ASX:ECS) is an Australian industrial hemp and medicinal cannabis company operating within the Pharmaceuticals, Biotechnology & Life Sciences sector. The company focuses on the organic cultivation and production of high-quality medicinal cannabis products, adhering to PIC/S GMP standards for comprehensive quality control from harvest to storage. Their business model emphasizes providing affordable, naturally grown products to end-users.

Director trades

14 trades recorded

DateDirectorTypeSharesPriceValue
2026-07-01Nan Maree Schoerie
other
3,750,000$0.004$15,000
2026-07-01Unknown Director
buy
---
2026-01-30Unknown Director
buy
---
2026-01-29Nan Maree Schoerie
exercise options
21,210,856$0.006$121,166.66
2025-06-23Unknown Director
buy
---
2025-06-20Nan Maree Schoerie
buy
1,000,000$0.009$9,000
2024-12-16Nan Maree Schoerie
other
25,000,000$0.009$220,287
2024-12-16Unknown Director
buy
---
2024-10-03Unknown Director
buy
---
2024-09-30Nan Maree Schoerie
buy
--$360,000
2024-07-01Unknown Director
buy
---
2024-06-27Nan Maree Schoerie
other
--$440,000
2024-05-06Unknown Director
buy
---
2024-05-02Mrs Nan Maree Schoerie
buy
6,666,667$0.015$100,000

ECS intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required